ALS does affect the heart, though not in the way most people assume. The disease does not directly attack heart muscle the way it destroys motor neurons, but it disrupts the autonomic nervous system’s control over heart rhythm, blood pressure, and cardiac electrical activity. Research over the past two decades has made it increasingly clear that cardiac autonomic dysfunction is a real and clinically meaningful part of ALS, one that can influence how patients feel day to day and, in some cases, how long they survive.
How ALS Reaches the Heart
ALS is defined by the progressive death of motor neurons in the brain and spinal cord, which is why muscle weakness and paralysis dominate the clinical picture. But the disease is not as neatly confined to motor neurons as textbooks once suggested. The autonomic nervous system, which controls involuntary functions like heart rate, blood pressure, digestion, and sweating, also takes damage in many patients. One study found autonomic deficits in about three-quarters of ALS patients, though most were mild. The most common abnormality was impaired cardiovagal function, present in about half of patients, along with sweating abnormalities in close to half as well.1PubMed Central. Autonomic system and ALS
The anatomical explanation involves structures deep in the spinal cord. Post-mortem studies have documented changes in the intermediolateral columns, clusters of neurons that relay commands from the brain to the sympathetic nervous system. When these cells degenerate, the balance between sympathetic (“fight or flight”) and parasympathetic (“rest and digest”) signaling to the heart shifts. In earlier disease stages, sympathetic activity tends to dominate. As ALS advances, sympathetic neurons themselves may fail, leaving the heart under predominant vagal influence and setting the stage for dangerous slowing of the heartbeat.2PubMed Central. Autonomic etiology of heart block in amyotrophic lateral sclerosis: a case report
Interestingly, one autopsy study of ALS patients examined the vagus nerve itself and found that the density of both myelinated and unmyelinated fibers was not significantly different from controls. That finding suggests the autonomic trouble in ALS is more about central degeneration of the command centers than about the peripheral nerves going to the heart physically falling apart.
Heart Rate Variability as a Window Into Cardiac Health
Heart rate variability, or HRV, refers to the natural fluctuation in the time between consecutive heartbeats. A healthy heart does not beat like a metronome; the intervals speed up and slow down in response to breathing, posture changes, stress, and other inputs. Higher variability generally reflects a heart that is well-regulated by the autonomic nervous system, while reduced variability is a red flag for impaired autonomic control.
HRV is the single most studied cardiac measure in ALS, and the findings are remarkably consistent. One early study found that ALS patients had a faster resting heart rate, reduced beat-to-beat variability, and a shifted ratio between low-frequency and high-frequency components of heart rate, all pointing to weakened parasympathetic control. These abnormalities were present regardless of how long a patient had been sick or how severe their motor symptoms were, suggesting the autonomic damage begins early and runs somewhat independently of the motor decline.3PubMed. Decreased heart rate variability in amyotrophic lateral sclerosis
More recent work using wearable sensors confirms these findings. A study comparing HRV metrics between ALS patients and healthy individuals found significant differences across nearly all measurements, with the ALS group consistently scoring lower.4PubMed Central. Analysis of Heart Rate Variability in Individuals Affected by Amyotrophic Lateral Sclerosis Holter monitoring studies have reported that multiple time-domain and frequency-domain HRV indicators are depressed in ALS patients compared to controls, and that roughly one in five patients develops orthostatic hypotension, a drop in blood pressure upon standing.
A particularly nuanced finding is that HRV reductions may be worse in ALS patients who also have cognitive impairment. Research comparing ALS patients with and without cognitive changes found that those with cognitive involvement had lower values across several key HRV indicators compared to both healthy controls and cognitively intact ALS patients.5PubMed Central. Association between cardiac autonomic dysfunction, cognitive impairment, and survival in patients with amyotrophic lateral sclerosis This makes sense biologically, since the frontotemporal brain regions involved in ALS-related cognitive decline overlap with areas that help regulate autonomic function.
QT Prolongation and the Risk of Sudden Cardiac Death
Beyond the heart’s rhythm variability, ALS also appears to affect the electrical activity within each heartbeat. The QT interval on an electrocardiogram represents the time it takes for the heart’s ventricles to electrically reset between beats. When this interval stretches too long, the heart becomes vulnerable to chaotic, potentially fatal arrhythmias.
A study tracking ALS patients over time found that the corrected QT interval and its dispersion (a measure of how unevenly the electrical signal spreads across the heart) increased significantly as the disease progressed from early to terminal stages. The researchers also counted neurons in the intermediolateral columns at autopsy and found a strong inverse correlation: fewer surviving neurons meant longer QT intervals. Two patients who suffered sudden cardiac arrest had particularly long QT intervals, large QT dispersion, and severe loss of these neurons.6PubMed. Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS
The combination of reduced HRV, sympathetic overactivity, and QT prolongation is recognized as a cluster of abnormalities that can predispose ALS patients to dangerous arrhythmias, potentially contributing to sudden cardiac death alongside respiratory decline.7PubMed. Cardiac Autonomic Dysfunction and Sudden Cardiac Death in Amyotrophic Lateral Sclerosis: Clinical Implications and Considerations for Care This is a relatively underappreciated cause of death in ALS. Most attention is rightly given to respiratory failure, which remains the leading cause, but an unknown fraction of “sudden” deaths may have a cardiac component that goes unrecognized.
What Cardiac MRI Reveals About the Heart Itself
A few studies have gone beyond electrical measurements and looked directly at the heart muscle using cardiac magnetic resonance imaging. One study found that the myocardium (heart muscle) showed increased T1 signal enhancement in roughly three-quarters of ALS patients, compared to about a quarter of controls. A trend toward patterns consistent with myocardial fibrosis, or scarring, was also seen in close to a quarter of patients. Heart mass was reduced compared to controls, and ejection volumes in both the left and right sides of the heart were decreased.
These findings are striking because they suggest ALS may involve subtle structural heart changes, not just electrical ones. However, this is a small body of evidence, and the clinical significance of these imaging findings is still being worked out. It is worth noting that the same study found normal Holter monitoring and normal troponin T in the imaging cohort, meaning the structural changes did not always translate into obvious arrhythmias or biomarker elevations detectable by standard tests.
The Troponin T Puzzle
If you have had a blood test after a suspected heart attack, your doctor probably checked your troponin levels. Troponin proteins leak into the blood when heart muscle cells are damaged, making them the gold-standard biomarker for cardiac injury. In ALS, something surprising happens: a specific form called cardiac troponin T is elevated in more than 60% of patients, while another form, cardiac troponin I, stays normal.8PubMed Central. Teaching an old dog new tricks: serum troponin T as a biomarker in amyotrophic lateral sclerosis
This discordance is the key to understanding the finding. If the heart were truly being damaged, both troponin T and troponin I would rise together. The fact that only troponin T goes up strongly suggests a non-cardiac source. Degrading and regenerating skeletal muscle produces proteins structurally similar to cardiac troponin T, and current lab assays cannot distinguish between the two.9Brain Communications. Plasma troponin T reflects lower motor neuron involvement on electromyography in amyotrophic lateral sclerosis In other words, the troponin T elevation in ALS is likely a signal of skeletal muscle breakdown, not heart damage.
This has real practical consequences. ALS patients who show up at an emergency room with elevated troponin T might be subjected to unnecessary cardiac workups, including invasive procedures, if clinicians are not aware of this phenomenon. Researchers have proposed that troponin T could actually be useful as a biomarker of lower motor neuron or skeletal muscle involvement in ALS. Levels tend to be higher in ALS patients than in both healthy controls and people with other conditions that mimic ALS, and the levels rise over time as the disease progresses.10PubMed. Cardiac troponin T is elevated and increases longitudinally in ALS patients However, troponin T does not appear to predict survival as strongly as neurofilament light chain, another biomarker that tracks neuronal damage more directly.
Stress Cardiomyopathy in ALS
Takotsubo cardiomyopathy, sometimes called “broken heart syndrome,” is a condition in which intense physical or emotional stress causes a sudden, temporary weakening of the heart muscle. The heart’s left ventricle balloons out and cannot pump effectively. Though usually reversible, it can be dangerous in the moment, causing heart failure symptoms like shortness of breath and low blood pressure.
There are documented cases of Takotsubo cardiomyopathy occurring in ALS patients, which makes physiological sense given the autonomic dysfunction and catecholamine surges that can occur in the disease. One case report describes an ALS patient who developed the syndrome after a fall, presenting with shortness of breath, generalized weakness, and dangerously low blood pressure.11PubMed Central. Takotsubo Cardiomyopathy Induced by Stress From Amyotrophic Lateral Sclerosis and a Mechanical Fall A study of a Sardinian ALS cohort identified potential triggers in several patients, including hospitalization for feeding tube placement and pneumonia.12PubMed Central. Takotsubo syndrome in a Sardinian amyotrophic lateral sclerosis cohort
The relevance here goes beyond rare case reports. ALS patients face repeated physical stressors, from infections and falls to invasive procedures and the psychological weight of the diagnosis itself. A nervous system already compromised in its ability to regulate cardiac function may be less able to buffer the heart from these surges of stress hormones, making Takotsubo a plausible and likely underdiagnosed complication.
Cardiac Autonomic Dysfunction and Survival
Perhaps the most clinically important question is whether cardiac autonomic dysfunction actually shortens the lives of ALS patients. Emerging evidence suggests it does. A study using Kaplan-Meier and Cox regression analyses found that patients with lower SDNN values (a key HRV metric reflecting overall autonomic control) at diagnosis had significantly worse survival. The study identified a cutoff value and showed that patients below it fared measurably worse even after adjusting for other factors. Patients diagnosed at more advanced stages and those with faster disease progression also showed more pronounced cardiac autonomic impairment.13PubMed Central. Cardiac autonomic dysfunction is associated with advanced stage, fast progression and poor survival in amyotrophic lateral sclerosis
Another prospective study confirmed this connection from a different angle, reporting that a higher burden of autonomic symptoms was independently associated with faster progression to the most advanced disease stage. The same study found that urinary complaints, a specific type of autonomic symptom, were an independent predictor of shorter survival.14PubMed Central. Autonomic dysfunction is associated with disease progression and survival in amyotrophic lateral sclerosis: a prospective longitudinal cohort study
These findings have not yet changed clinical guidelines in any dramatic way, but they suggest that routine HRV monitoring or autonomic testing at diagnosis could help identify patients at higher risk. Whether intervening on the autonomic dysfunction itself, through medication or ventilatory strategies, would improve outcomes remains an open question.
Riluzole and Blood Pressure
Riluzole is one of the few drugs approved to slow ALS progression, and it has a cardiovascular side effect worth knowing about. A study comparing blood pressure in riluzole-treated ALS patients, untreated ALS patients, and healthy controls found that 80% of patients on riluzole had blood pressure elevations, with a median reading of 140/86. That compared to 120/70 in healthy controls and a systolic pressure of 126 in untreated ALS patients.15PubMed. Blood pressure elevations in riluzole-treated patients with amyotrophic lateral sclerosis
The mechanism is not fully understood, but in a patient population already dealing with autonomic instability, adding a drug that raises blood pressure deserves monitoring. Clinicians managing ALS patients on riluzole should be checking blood pressure regularly and treating hypertension when appropriate, just as they would in any other patient.
Noninvasive Ventilation and Heart Rhythm
Noninvasive ventilation is one of the most important interventions in ALS, primarily used to manage the respiratory muscle weakness that defines the later stages of the disease. But the choice of ventilator mode may also influence cardiac autonomic function. Research has found that different ventilatory modes produce different patterns of autonomic activation, with some modes favoring stronger vagal (parasympathetic) tone during sleep. Specifically, the timing of the ventilator’s inspiratory and expiratory phases appears to correlate with shifts in the sympathetic-parasympathetic balance measured through HRV.
This is still early-stage research, and no one is selecting ventilator settings based on cardiac outcomes yet. But the concept is appealing: if a treatment ALS patients already use for breathing can be tuned to also stabilize heart rhythm, that is a meaningful secondary benefit worth investigating further.
A Surprising Cardiometabolic Profile
One of the more unexpected findings in ALS research is that patients often arrive at diagnosis with a cardiometabolic profile that looks, on paper, healthier than the general population. A study of ALS patients found that fewer women in the ALS group were obese compared to the general population, more men had a normal body mass index, a higher percentage had never smoked, and the prevalence of dyslipidemia (abnormal cholesterol and fat levels) was substantially lower than in the general population.16PubMed. Cardiometabolic health and risk of amyotrophic lateral sclerosis
This paradox has fueled ongoing debate about whether certain metabolic profiles might predispose people to ALS, whether pre-disease lifestyle factors play a role, or whether the finding is partly an artifact of how ALS patients are identified and compared. Some researchers have speculated that a higher metabolic rate or leaner body composition could reflect an underlying biological susceptibility. Others point out that ALS patients who are leaner at diagnosis tend to have worse outcomes, since having caloric reserves appears protective once the disease starts consuming muscle. Either way, the pattern is consistent enough across studies to be considered a genuine feature of the ALS population, and it adds another layer to the complex relationship between ALS and the cardiovascular system. The heart-related effects of ALS may play out against a metabolic backdrop that is quite different from what clinicians see in most cardiac patients.